LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.
Zhao W, Geng D, Li S, Chen Z, Sun M. · 2018
Read LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. by Zhao W, Geng D, Li S, Chen Z, Sun M. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5852357.txt.
Introduction
Zhao and co-authors trace a three-link RNA chain that drives breast cancer growth. Their study appeared in Cancer Medicine. The long noncoding RNA HOTAIR runs high in breast tumors. Silencing it slowed cell growth and invasion in the lab.
HOTAIR works by sponging up a microRNA, miR-20a-5p. Freed from that brake, the gene HMGA2 pushes cells to multiply and spread. Restoring the microRNA reversed the cancer cells' behavior. Mouse xenografts confirmed the chain operates in living tumors. Breaking any link of the axis could become a therapy.
Catalog record
| CREATOR | Zhao W, Geng D, Li S, Chen Z, Sun M. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA2 axis in breast cancer By Wenyan Zhao, Donghua Geng, Shuqiang Li, Zhaofu Chen, Ming Sun Published in: Cancer Medicine DOI: 10.1002/cam4.1353 ABSTRACT Abstract To study the regulatory effect of lncRNA HOTAIR/miR‐20a‐5p/HMGA2 axis on breast cancer (BC) cell growth, cell mobility, invasiveness, and apoptosis. The microarray data of lncRNAs and mRNAs with differential expression in BC tissues were analyzed in the Cancer Genome Atlas (TCGA) database. LncRNA HOX transcript antisense RNA (lncRNA HOTAIR) expression in BC was assessed by qRT‐PCR. Cell viability was confirmed using MTT and colony formation assay. Cell apoptosis was analyzed by TdT‐mediated dUTP nick‐end labeling (TUNEL) assay. Cell mobility and invasiveness were testified by transwell assay. RNA pull‐down and dual luciferase assay were used for analysis of the correlation between lncRNA HOTAIR and miR‐20a‐5p, as well as relationship of miR‐20a‐5p with high mobility group AT‐hook 2 (HMGA2). Tumor xenograft study was applied to confirm the correlation of lncRNA HOTAIR/miR‐20a‐5p/HMGA2 axis on BC development in vivo. The expression levels of the lncRNA HOTAIR were upregulated in BC tissues and cells. Knockdown lncRNA HOTAIR inhibited cell propagation and metastasis and facilitated cell apoptosis. MiR‐20a‐5p was a target of lncRNA HOTAIR and had a negative correlation with lncRNA HOTAIR. MiR‐20a‐5p overexpression in BC suppressed cell growth, mobility, and invasiveness and facilitated apoptosis. HMGA2 was a target of miR‐20a‐5p, which significantly induced carcinogenesis of BC. BC cells progression was mediated by lncRNA HOTAIR via affecting miR‐20a‐5p/HMGA2 in vivo. LncRNA HOTAIR affected cell growth, metastasis, and apoptosis via the miR‐20a‐5p/HMGA2 axis in breast cancer. INTRODUCTION Breast cancer (BC) is considered the leading cause of cancer‐related death in women worldwide 1, 2, 3, 4. At present, gene therapy against neoplasms has been a novel research focus in cancer treatment 5, 6. Using gene therapy against BC, it is an urgent need to elucidate novel mechanisms correlated with BC development. Noncoding RNAs (ncRNAs) have become the focus of “next generation” biology 7, which consist of long noncoding RNAs (lncRNAs) and microRNAs (miRNAs). Until now, a few lncRNAs have been demonstrated to be dysregulated in breast cancer, which is closely related to breast cancer diagnosis and prognosis 8, 9. HOX transcript antisense intergenic RNA (HOTAIR) located in chromosome 12 and owned 2.2 kb in length approximately, which is transcribed from the HOXC locus and epigenetically acts as a repressor of HOXD 10. In addition, lncRNA HOTAIR has been found to be closely associated with cell metastasis in multiple cancers, such as colorectal 11, hepatocellular 12, pancreatic 13, gastrointestinal stromal 14, lung 15, and breast 16 carcinomas. Notably, HOTAIR expression is increased in breast cancer, which provides a powerful biomarker of tumor metastases and patient death 16, 17. However, the molecular mechanism of HOTAIR in BC remains unknown. MiRNAs are short (20‐22 nt), noncoding, and highly stable RNAs that are involved in post‐transcriptional regulation of gene expression 18. Dysregulation of miRNAs is a major culprit of tumorigenesis in breast cancers because their loss leads to the increased expression of targeted genes, including oncogenes. For example, Browne et al. 19 showed that miR‐378‐mediated suppression of Runx1 alleviated the aggressive phenotype of triple‐negative MDA‐MB‐231 human breast cancer cells. Playing the role of cancer inhibitor, miR‐20a‐5p has been found to be downregulated in the majority of cancer cells. For example, miR‐20a‐5p was confirmed to repress MICA and MICB expression by binding to the mRNA 3′‐UTRs in human cancer cells (mainly HeLa, 293T, DU145 cells) 20. Meanwhile, miR‐20a‐5p was also experimentally verified as new pharmacogenomic biomarkers for metformin in MCF‐7 or MDA‐MB‐231 cell lines 21. Therefore, it is suggested that miR‐20a‐5p may hold great promise as an accessible biomarker for BC. However, the role of miR‐20a‐5p in breast cancer needs to be further illuminated. High mobility group AT‐hook 2 (HMGA2) binds to AT‐rich regions in DNA, altering chromatin architecture 22 to promote the action of transcriptional enhancers. HMGA2 is highly expressed in most malignant epithelial tumors, including breast 23, pancreas 24, and nonsmall cell lung cancer 25, suggesting that HMGA2 could promote tumor progression in breast cancer. In this study, we explored the role of lncRNA HOTAIR/miR‐20a‐5p/HMGA2 axis in the development of BC. LncRNA HOTAIR functioned as the sponge of miR‐20a‐5p to upregulate HMGA2 expression. Therefore, decrease in lncRNA HOTAIR may serve as prognostic as well as predication marker for BC patients and used as a novel therapeutic target. MATERIALS AND METHODS Clinical samples A total of 20 BC patients who underwent a mastectomy at Shengjing Hospital Affiliated China Medical University were recruited to the study. All specimens were pathologically confirmed as breast cancer and did not receive radiotherapy or chemotherapy prior to surgery. After resection, the tumor and adjacent tissues were frozen by liquid nitrogen, and the specimens were immediately stored at −80°C. The Ethics Committee of Shengjing Hospital Affiliated China Medical University approved this study, and written informed consents were acquired from all enrolled patients. Bioinformatics analysis LncRNAs and mRNAs with differential expressions in BC tissues were analyzed in the Cancer Genome Atlas (TCGA) database (https://cancergenome.nih.gov/). Differentially expressed lncRNA and mRNA were identified using a t‐test (P < 0.05) combined with fold change (FC) (log2(FC)>2 for upregulated lncRNAs and log2(FC)<2 for downregulated lncRNAs). The Kaplan‐Meier curve was used to test lncRNA association with time to progression. The binding sites between lncRNA HOTAIR and miR‐20a‐5p, and the target genes of miR‐20a‐5p were predicted using miRcode (http://www.mircode.org/) and TargetScan 7.1 database (www.targetscan.org). Cell culture Three BC carcinoma cell lines MCF7, SKBR3, MDA‐MB‐231 and human breast epithelial cell lines MCF‐10A were all purchased from BeNa Culture Collection Biological Technology Co., Ltd. (Beijing, China). Breast cancer cell lines MCF7 and MDA‐MB‐231 were cultured in Dulbecco's Modified Eagle Medium (DMEM, Gibco) supplemented with 10% FBS and 100 U/mL Penicillin/Streptomycin in a 5% CO2 incubator. SKBR3 were cultured in McCoy's 5A Media (modified with tricine) and MCF‐10A was cultured in RPMI‐1640. Cells were collected at 90% confluence, and the medium was changed every 48–72 h. Cell transfection MDA‐MB‐231 cells at exponential stage were used for transfection. Before transfection, 1 × 106 BC cells were cultured in 6‐well plates with 2 mL complete medium for 24 h until they were 90% confluent. Si‐HOTAIR, hsa‐miR‐20a‐5p mimics, hsa‐miR‐20a‐5p inhibitor, si‐HMGA2, pCDNA‐HMGA2, and negative control (NC) were purchased from Shanghai GenePharma Inc. (Shanghai, China). The vectors and microRNAs were transfected, respectively, into MDA‐MB‐231 cell line by Lipofectamine 3000 reagents and cultured with Opti‐MEM serum‐free medium following the instructions. Cells were grouped into (1) NC group; (2) si‐HOTAIR group; (3) miR‐20a‐5p‐mimics group; (4) miR‐20a‐5p‐inhibitor group; (5) si‐HOTAIR+miR‐20a‐5p‐inhibitor group; (6) HMGA2 group; (7) si‐HMGA2 group; (8) HMGA2 + miR‐20a‐5p‐mimics group. qRT‐PCR The total RNA from BC tissues and cells was extracted by TRIzol® reagent (Invitrogen, Carlsbad, CA, USA), and 200 ng extracted RNA was reverse transcribed into cDNA by ReverTra Ace qPCR RT Kit (Toyobo, Japan) before qRT‐PCR. Quantitative PCR was carried out using THUNDERBIRD SYBR® qPCR Mix (Toyobo, Japan) and a LightCycler 480 Real‐Time PCR system (Roche, Shanghai, China). The GAPDH and U6 gene was used as an endogenous control gene for normalizing the expression of target genes. Each sample was analyzed in triplicate. The thermo‐cycling program consisted of holding at 94°C for 2 min, followed by